• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于黏膜黏附纳米颗粒的给药系统在黏膜疫苗中的研发。

The Mucoadhesive Nanoparticle-Based Delivery System in the Development of Mucosal Vaccines.

机构信息

Taizhou Central Hospital (Taizhou University Hospital), Taizhou University, Taizhou, Zhejiang, 318000, People's Republic of China.

Institute of Nanobiomaterials and Immunology, School of Life Science, Taizhou University, Taizhou, Zhejiang, 318000, People's Republic of China.

出版信息

Int J Nanomedicine. 2022 Sep 28;17:4579-4598. doi: 10.2147/IJN.S359118. eCollection 2022.

DOI:10.2147/IJN.S359118
PMID:36199476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9527817/
Abstract

Mucosal tissue constitutes the largest interface between the body and the external environment, regulating the entry of pathogens, particles, and molecules. Mucosal immunization is the most effective way to trigger a protective mucosal immune response. However, the majority of the currently licensed vaccines are recommended to be administered by intramuscular injection, which has obvious shortcomings, such as high production costs, low patient compliance, and lack of mucosal immune response. Strategies for eliciting mucosal and systemic immune responses are being developed, including appropriate vaccine adjuvant, delivery system, and bacterial or viral vectors. Biodegradable mucoadhesive nanoparticles (NPs) are the most promising candidate for vaccine delivery systems due to their inherent immune adjuvant property and the ability to protect the antigen from degradation, sustain the release of loaded antigen, and increase the residence time of antigen at the administration site. The current review outlined the complex structure of mucosa, the mechanism of interaction between NPs and mucosa, factors affecting the mucoadhesion of NPs, and the application of the delivery system based on mucoadhesive NPs in the field of vaccines. Moreover, this review demonstrated that the biodegradable and mucoadhesive NP-based delivery system has the potential for mucosal administration of vaccines.

摘要

黏膜组织构成了机体与外界环境之间最大的界面,调节病原体、颗粒和分子的进入。黏膜免疫接种是触发保护性黏膜免疫应答的最有效方法。然而,目前大多数许可的疫苗都建议通过肌肉注射给药,这种方法存在明显的缺点,如生产成本高、患者顺应性低以及缺乏黏膜免疫应答。正在开发引发黏膜和全身免疫应答的策略,包括适当的疫苗佐剂、传递系统以及细菌或病毒载体。由于具有固有免疫佐剂特性以及保护抗原免受降解、持续释放负载抗原和增加抗原在给药部位停留时间的能力,可生物降解的黏膜黏附纳米颗粒(NPs)是最有前途的疫苗传递系统候选物。本文综述了黏膜的复杂结构、NPs 与黏膜相互作用的机制、影响 NPs 黏膜黏附的因素以及基于黏膜黏附 NPs 的传递系统在疫苗领域的应用。此外,本综述表明,基于可生物降解和黏膜黏附的 NP 传递系统具有黏膜给予疫苗的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ab/9527817/20f1ffa58bdc/IJN-17-4579-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ab/9527817/2df1728b88b6/IJN-17-4579-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ab/9527817/801b3a7c772f/IJN-17-4579-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ab/9527817/c34416e2ddbe/IJN-17-4579-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ab/9527817/d27cf5850be4/IJN-17-4579-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ab/9527817/20f1ffa58bdc/IJN-17-4579-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ab/9527817/2df1728b88b6/IJN-17-4579-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ab/9527817/801b3a7c772f/IJN-17-4579-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ab/9527817/c34416e2ddbe/IJN-17-4579-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ab/9527817/d27cf5850be4/IJN-17-4579-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ab/9527817/20f1ffa58bdc/IJN-17-4579-g0005.jpg

相似文献

1
The Mucoadhesive Nanoparticle-Based Delivery System in the Development of Mucosal Vaccines.基于黏膜黏附纳米颗粒的给药系统在黏膜疫苗中的研发。
Int J Nanomedicine. 2022 Sep 28;17:4579-4598. doi: 10.2147/IJN.S359118. eCollection 2022.
2
Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.基于聚合物纳米颗粒的黏膜疫苗佐剂和传递系统。
Int J Pharm. 2019 Dec 15;572:118731. doi: 10.1016/j.ijpharm.2019.118731. Epub 2019 Oct 24.
3
Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.新型佐剂鼻用疫苗的研发:与壳聚糖纳米颗粒结合的C48/80作为增强黏膜免疫的途径
Eur J Pharm Biopharm. 2015 Jun;93:149-64. doi: 10.1016/j.ejpb.2015.03.024. Epub 2015 Mar 26.
4
Mucosal Vaccine Delivery Using Mucoadhesive Polymer Particulate Systems.黏膜疫苗递呈用黏附聚合物微粒系统。
Tissue Eng Regen Med. 2021 Oct;18(5):693-712. doi: 10.1007/s13770-021-00373-w. Epub 2021 Jul 25.
5
Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery.功能性壳聚糖基复合纳米颗粒作为鼻腔内递呈疫苗佐剂增强黏膜免疫应答。
ACS Appl Mater Interfaces. 2022 Nov 30;14(47):52691-52701. doi: 10.1021/acsami.2c17627. Epub 2022 Nov 16.
6
Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.用于鼻腔疫苗递送的表面改性聚乳酸-羟基乙酸共聚物纳米颗粒的研制与表征:粘膜粘附性包衣对抗原摄取和免疫佐剂活性的影响
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):550-9. doi: 10.1016/j.ejpb.2013.06.017. Epub 2013 Jul 4.
7
Chrysanthemum sporopollenin: A novel vaccine delivery system for nasal mucosal immunity.野菊花类脂体:鼻腔黏膜免疫新型疫苗传递系统。
Front Immunol. 2023 Feb 9;14:1132129. doi: 10.3389/fimmu.2023.1132129. eCollection 2023.
8
Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.疫苗黏膜递呈的最新进展:黏膜黏附/可生物降解聚合物载体的作用。
Expert Opin Ther Pat. 2010 May;20(5):661-79. doi: 10.1517/13543771003730425.
9
Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers.疫苗的黏膜给药:黏膜黏附性/可生物降解聚合物的作用
Recent Pat Drug Deliv Formul. 2010 Jun;4(2):114-28. doi: 10.2174/187221110791185015.
10
Mucosal Adjuvants Delivered by a Mucoadhesive Patch for Sublingual Administration of Subunit Vaccines.黏膜佐剂经黏膜黏附贴片经舌下给药用于亚单位疫苗。
Int J Mol Sci. 2022 Nov 3;23(21):13440. doi: 10.3390/ijms232113440.

引用本文的文献

1
The Pharmaceutical and Pharmacological Potential Applications of Bilosomes as Nanocarriers for Drug Delivery.双分子层脂质体作为药物递送纳米载体的药学和药理学潜在应用
Molecules. 2025 Mar 6;30(5):1181. doi: 10.3390/molecules30051181.
2
Multilayer Adjuvanted Influenza Protein Nanoparticles Improve Intranasal Delivery and Antigen-Specific Immunity.多层佐剂流感蛋白纳米颗粒改善鼻内给药及抗原特异性免疫。
ACS Nano. 2025 Feb 25;19(7):7005-7025. doi: 10.1021/acsnano.4c14735. Epub 2025 Feb 15.
3
Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine.

本文引用的文献

1
Vaginal drug delivery approaches for localized management of cervical cancer.阴道给药途径用于宫颈癌的局部治疗。
Adv Drug Deliv Rev. 2021 Jul;174:114-126. doi: 10.1016/j.addr.2021.04.009. Epub 2021 Apr 20.
2
Human gut-associated lymphoid tissues (GALT); diversity, structure, and function.人体肠道相关淋巴组织(GALT);多样性、结构与功能。
Mucosal Immunol. 2021 Jul;14(4):793-802. doi: 10.1038/s41385-021-00389-4. Epub 2021 Mar 22.
3
Evaluation of Mucosal and Systemic Vaccine Responses by Cyclic di-GMP (CDG)-adjuvanted Protein Subunit Vaccines.
通过鼻内给予HA嵌合多表位纳米颗粒疫苗对同源和异源流感病毒的交叉保护作用。
J Nanobiotechnology. 2025 Feb 4;23(1):77. doi: 10.1186/s12951-025-03122-6.
4
Oral Vaccine Formulation for Immunocastration Using a Live-Attenuated ΔSPI2 Strain as an Antigenic Vector.使用减毒活ΔSPI2菌株作为抗原载体的免疫去势口服疫苗制剂。
Vaccines (Basel). 2024 Dec 12;12(12):1400. doi: 10.3390/vaccines12121400.
5
Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals.高效N2B递送的纳米技术方法:从小分子药物到生物制药。
Beilstein J Nanotechnol. 2024 Nov 12;15:1400-1414. doi: 10.3762/bjnano.15.113. eCollection 2024.
6
Precious Cargo: The Role of Polymeric Nanoparticles in the Delivery of Covalent Drugs.珍贵货物:聚合物纳米粒子在共价药物传递中的作用。
Molecules. 2024 Oct 19;29(20):4949. doi: 10.3390/molecules29204949.
7
Overcoming Biopotency Barriers: Advanced Oral Delivery Strategies for Enhancing the Efficacy of Bioactive Food Ingredients.克服生物功效障碍:提高生物活性食品成分功效的先进口服递送策略。
Adv Sci (Weinh). 2024 Nov;11(44):e2401172. doi: 10.1002/advs.202401172. Epub 2024 Oct 3.
8
A Dual-Adjuvanted Parenteral-Intranasal Subunit Nanovaccine generates Robust Systemic and Mucosal Immunity Against SARS-CoV-2 in Mice.一种双佐剂肠胃外-鼻内亚单位纳米疫苗在小鼠中产生针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的强大全身和黏膜免疫。
Adv Sci (Weinh). 2024 Dec;11(45):e2402792. doi: 10.1002/advs.202402792. Epub 2024 Oct 1.
9
Evaluation of the Immunity Responses in Mice to Recombinant Displaying Newcastle Disease Virus Protein Truncations.小鼠对展示新城疫病毒蛋白截短体的重组体的免疫反应评估。
Microorganisms. 2024 Feb 21;12(3):439. doi: 10.3390/microorganisms12030439.
10
Chitosan and Anionic Solubility Enhancer Sulfobutylether-β-Cyclodextrin-Based Nanoparticles as Dexamethasone Ophthalmic Delivery System for Anti-Inflammatory Therapy.壳聚糖与基于阴离子溶解性增强剂磺丁基醚-β-环糊精的纳米颗粒作为地塞米松眼用给药系统用于抗炎治疗
Pharmaceutics. 2024 Feb 16;16(2):277. doi: 10.3390/pharmaceutics16020277.
环状二鸟苷单磷酸(CDG)佐剂蛋白亚单位疫苗对黏膜和全身疫苗反应的评估
Bio Protoc. 2019 Apr 20;9(8):e3217. doi: 10.21769/BioProtoc.3217.
4
Natural Derived Nasal Spray; A Proposed Approach for COVID-19 Disease Control.天然鼻腔喷雾;一种用于 COVID-19 疾病控制的建议方法。
Infect Disord Drug Targets. 2021;21(8):e160921191568. doi: 10.2174/1871526521666210218201113.
5
Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine.下一代聚膦嗪免疫佐剂:基于人乳头瘤病毒 VLPs 疫苗的合成、自组装和体内效力。
Nanomedicine. 2021 Apr;33:102359. doi: 10.1016/j.nano.2021.102359. Epub 2021 Jan 18.
6
Analytical characterization of liposomes and other lipid nanoparticles for drug delivery.用于药物递送的脂质体和其他脂质纳米粒的分析特性。
J Pharm Biomed Anal. 2021 Jan 5;192:113642. doi: 10.1016/j.jpba.2020.113642. Epub 2020 Sep 19.
7
Potent Protective Immune Responses to Induced by Virus-Like Particle Vaccine in Pigs.猪用病毒样颗粒疫苗诱导产生的强效保护性免疫反应。
Vaccines (Basel). 2020 Sep 15;8(3):532. doi: 10.3390/vaccines8030532.
8
Rabies VLPs adjuvanted with saponin-based liposomes induce enhanced immunogenicity mediated by neutralizing antibodies in cattle, dogs and cats.狂犬病 VLPs 与皂素基脂质体佐剂联合使用,可在牛、犬和猫中诱导由中和抗体介导的增强免疫原性。
J Virol Methods. 2020 Dec;286:113966. doi: 10.1016/j.jviromet.2020.113966. Epub 2020 Sep 6.
9
Zwitterion-functionalized mesoporous silica nanoparticles for enhancing oral delivery of protein drugs by overcoming multiple gastrointestinal barriers.两性离子功能化介孔二氧化硅纳米粒子通过克服多种胃肠道屏障增强蛋白质药物的口服递送
J Colloid Interface Sci. 2021 Jan 15;582(Pt A):364-375. doi: 10.1016/j.jcis.2020.08.010. Epub 2020 Aug 17.
10
Editorial: The Role of Innate Lymphoid Cells in Mucosal Immunity.社论:固有淋巴细胞在黏膜免疫中的作用
Front Immunol. 2020 Jun 17;11:1233. doi: 10.3389/fimmu.2020.01233. eCollection 2020.